Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of Slc2a4 Gene Expression in 3T3-L1 Adipocytes

Advanced glycated end products (AGEs) are cytotoxic compounds that are mainly increased in diabetes mellitus (DM), kidney failure, inflammation, and in response to the ingestion of AGE-rich diets. AGEs can also impair glycemic homeostasis by decreasing the expression of the (solute carrier family 2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2024-08, Vol.25 (15), p.8242
Hauptverfasser: Michalani, Maria Luiza Estimo, Passarelli, Marisa, Machado, Ubiratan Fabres
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 15
container_start_page 8242
container_title International journal of molecular sciences
container_volume 25
creator Michalani, Maria Luiza Estimo
Passarelli, Marisa
Machado, Ubiratan Fabres
description Advanced glycated end products (AGEs) are cytotoxic compounds that are mainly increased in diabetes mellitus (DM), kidney failure, inflammation, and in response to the ingestion of AGE-rich diets. AGEs can also impair glycemic homeostasis by decreasing the expression of the (solute carrier family 2 member 4) gene and its GLUT4 (solute carrier family 2, facilitated glucose transporter member 4) protein in muscle. However, the mechanisms underlying AGE's effect on adipocytes have not been demonstrated yet. This study investigated the effects of AGEs upon /GLUT4 expression in 3T3-L1 adipocytes, as well as the potential role of NFKB (nuclear factor NF-kappa-B) activity in the effects observed. Adipocytes were cultured in the presence of control albumin (CA) or advanced glycated albumin (GA) at concentrations of 0.4, 3.6, and 5.4 mg/mL for 24 h or 72 h. , and mRNAs were measured by RT-qPCR, GLUT4, IKKA/B, and p50/p65 NFKB subunits using Western blotting, and p50/p65 binding into the promoter was analyzed by chromatin immunoprecipitation (ChIP) assay. GA at 0.4 mg/mL increased /GLUT4 expression after 24 h and 72 h (from 50% to 100%), but at 5.4 mg/mL, /GLUT4 expression decreased at 72 h (by 50%). and expression increased after 24 h at all concentrations, but this effect was not observed at 72 h. Furthermore, 5.4 mg/mL of GA increased the p50/p65 nuclear content and binding into at 72 h. In summary, this study reveals AGE-induced and NFKB-mediated repression of /GLUT4 expression. This can compromise the adipocyte glucose utilization, contributing not only to the worsening of glycemic control in DM subjects but also the impairment of glycemic homeostasis in non-DM subjects under the high intake of AGE-rich foods.
doi_str_mv 10.3390/ijms25158242
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3091287489</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A804511435</galeid><sourcerecordid>A804511435</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-20abe17f916fb5d64efd0e2e12dd02eda7e520c4b460d4fec43d2f2474e5c8033</originalsourceid><addsrcrecordid>eNptkc1v1DAQxS0EoqVw44wsceFAij22N8lxqbZLxfIhKOfIa4_Bq8RO7QSxd_5wvGopBSEfxvL7zZuRHyFPOTsVomWv_G7IoLhqQMI9cswlQMXYor5_535EHuW8YwwEqPYhORItB9Vwfkx-vp9NjzrRc22mmKq3ehx19Zq-Q-v1hJlO35Au7XcdDFq67vdGTz4GugqWfkzRzmaqLkIpRf2EY8KcD3J09HNvQEu6xoB09eNW8YGKS1FteHH1YzT7MuQxeeB0n_HJTT0hX85Xl2dvqs2H9cXZclMZwflUAdNb5LVr-cJtlV1IdJYhIAdrGaDVNSpgRm7lglnp0EhhwYGsJSrTMCFOyItr3zHFqxnz1A0-G-x7HTDOuROs_EtTy6Yt6PN_0F2cUyjbHSjWSikA_lBfdY-dDy5OSZuDabdsmFScS6EKdfofqhyLgzcxoPPl_a-Gl9cNJsWcE7puTH7Qad9x1h1C7-6GXvBnN7vO2wHtLfw7ZfELsQSlOw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3090944322</pqid></control><display><type>article</type><title>Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of Slc2a4 Gene Expression in 3T3-L1 Adipocytes</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Michalani, Maria Luiza Estimo ; Passarelli, Marisa ; Machado, Ubiratan Fabres</creator><creatorcontrib>Michalani, Maria Luiza Estimo ; Passarelli, Marisa ; Machado, Ubiratan Fabres</creatorcontrib><description>Advanced glycated end products (AGEs) are cytotoxic compounds that are mainly increased in diabetes mellitus (DM), kidney failure, inflammation, and in response to the ingestion of AGE-rich diets. AGEs can also impair glycemic homeostasis by decreasing the expression of the (solute carrier family 2 member 4) gene and its GLUT4 (solute carrier family 2, facilitated glucose transporter member 4) protein in muscle. However, the mechanisms underlying AGE's effect on adipocytes have not been demonstrated yet. This study investigated the effects of AGEs upon /GLUT4 expression in 3T3-L1 adipocytes, as well as the potential role of NFKB (nuclear factor NF-kappa-B) activity in the effects observed. Adipocytes were cultured in the presence of control albumin (CA) or advanced glycated albumin (GA) at concentrations of 0.4, 3.6, and 5.4 mg/mL for 24 h or 72 h. , and mRNAs were measured by RT-qPCR, GLUT4, IKKA/B, and p50/p65 NFKB subunits using Western blotting, and p50/p65 binding into the promoter was analyzed by chromatin immunoprecipitation (ChIP) assay. GA at 0.4 mg/mL increased /GLUT4 expression after 24 h and 72 h (from 50% to 100%), but at 5.4 mg/mL, /GLUT4 expression decreased at 72 h (by 50%). and expression increased after 24 h at all concentrations, but this effect was not observed at 72 h. Furthermore, 5.4 mg/mL of GA increased the p50/p65 nuclear content and binding into at 72 h. In summary, this study reveals AGE-induced and NFKB-mediated repression of /GLUT4 expression. This can compromise the adipocyte glucose utilization, contributing not only to the worsening of glycemic control in DM subjects but also the impairment of glycemic homeostasis in non-DM subjects under the high intake of AGE-rich foods.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms25158242</identifier><identifier>PMID: 39125811</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>3T3-L1 Cells ; Adipocytes ; Adipocytes - drug effects ; Adipocytes - metabolism ; Age ; Animals ; Biotechnology industry ; Body fat ; Dextrose ; Diabetes ; Ethylenediaminetetraacetic acid ; Gene expression ; Gene Expression Regulation - drug effects ; Glucose ; Glucose Transporter Type 4 - genetics ; Glucose Transporter Type 4 - metabolism ; Glycation End Products, Advanced - metabolism ; Glycation End Products, Advanced - pharmacology ; Homeostasis ; Insulin resistance ; Kinases ; Localization ; Mice ; Musculoskeletal system ; Neurophysiology ; NF-kappa B - metabolism ; NF-kappa B p50 Subunit - genetics ; NF-kappa B p50 Subunit - metabolism ; Oxidative stress ; Phosphorylation ; Promoter Regions, Genetic ; Proteins ; Transcription Factor RelA - genetics ; Transcription Factor RelA - metabolism</subject><ispartof>International journal of molecular sciences, 2024-08, Vol.25 (15), p.8242</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c311t-20abe17f916fb5d64efd0e2e12dd02eda7e520c4b460d4fec43d2f2474e5c8033</cites><orcidid>0000-0002-7914-0107 ; 0000-0002-8237-2435 ; 0000-0002-9249-4698</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39125811$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Michalani, Maria Luiza Estimo</creatorcontrib><creatorcontrib>Passarelli, Marisa</creatorcontrib><creatorcontrib>Machado, Ubiratan Fabres</creatorcontrib><title>Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of Slc2a4 Gene Expression in 3T3-L1 Adipocytes</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Advanced glycated end products (AGEs) are cytotoxic compounds that are mainly increased in diabetes mellitus (DM), kidney failure, inflammation, and in response to the ingestion of AGE-rich diets. AGEs can also impair glycemic homeostasis by decreasing the expression of the (solute carrier family 2 member 4) gene and its GLUT4 (solute carrier family 2, facilitated glucose transporter member 4) protein in muscle. However, the mechanisms underlying AGE's effect on adipocytes have not been demonstrated yet. This study investigated the effects of AGEs upon /GLUT4 expression in 3T3-L1 adipocytes, as well as the potential role of NFKB (nuclear factor NF-kappa-B) activity in the effects observed. Adipocytes were cultured in the presence of control albumin (CA) or advanced glycated albumin (GA) at concentrations of 0.4, 3.6, and 5.4 mg/mL for 24 h or 72 h. , and mRNAs were measured by RT-qPCR, GLUT4, IKKA/B, and p50/p65 NFKB subunits using Western blotting, and p50/p65 binding into the promoter was analyzed by chromatin immunoprecipitation (ChIP) assay. GA at 0.4 mg/mL increased /GLUT4 expression after 24 h and 72 h (from 50% to 100%), but at 5.4 mg/mL, /GLUT4 expression decreased at 72 h (by 50%). and expression increased after 24 h at all concentrations, but this effect was not observed at 72 h. Furthermore, 5.4 mg/mL of GA increased the p50/p65 nuclear content and binding into at 72 h. In summary, this study reveals AGE-induced and NFKB-mediated repression of /GLUT4 expression. This can compromise the adipocyte glucose utilization, contributing not only to the worsening of glycemic control in DM subjects but also the impairment of glycemic homeostasis in non-DM subjects under the high intake of AGE-rich foods.</description><subject>3T3-L1 Cells</subject><subject>Adipocytes</subject><subject>Adipocytes - drug effects</subject><subject>Adipocytes - metabolism</subject><subject>Age</subject><subject>Animals</subject><subject>Biotechnology industry</subject><subject>Body fat</subject><subject>Dextrose</subject><subject>Diabetes</subject><subject>Ethylenediaminetetraacetic acid</subject><subject>Gene expression</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Glucose</subject><subject>Glucose Transporter Type 4 - genetics</subject><subject>Glucose Transporter Type 4 - metabolism</subject><subject>Glycation End Products, Advanced - metabolism</subject><subject>Glycation End Products, Advanced - pharmacology</subject><subject>Homeostasis</subject><subject>Insulin resistance</subject><subject>Kinases</subject><subject>Localization</subject><subject>Mice</subject><subject>Musculoskeletal system</subject><subject>Neurophysiology</subject><subject>NF-kappa B - metabolism</subject><subject>NF-kappa B p50 Subunit - genetics</subject><subject>NF-kappa B p50 Subunit - metabolism</subject><subject>Oxidative stress</subject><subject>Phosphorylation</subject><subject>Promoter Regions, Genetic</subject><subject>Proteins</subject><subject>Transcription Factor RelA - genetics</subject><subject>Transcription Factor RelA - metabolism</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkc1v1DAQxS0EoqVw44wsceFAij22N8lxqbZLxfIhKOfIa4_Bq8RO7QSxd_5wvGopBSEfxvL7zZuRHyFPOTsVomWv_G7IoLhqQMI9cswlQMXYor5_535EHuW8YwwEqPYhORItB9Vwfkx-vp9NjzrRc22mmKq3ehx19Zq-Q-v1hJlO35Au7XcdDFq67vdGTz4GugqWfkzRzmaqLkIpRf2EY8KcD3J09HNvQEu6xoB09eNW8YGKS1FteHH1YzT7MuQxeeB0n_HJTT0hX85Xl2dvqs2H9cXZclMZwflUAdNb5LVr-cJtlV1IdJYhIAdrGaDVNSpgRm7lglnp0EhhwYGsJSrTMCFOyItr3zHFqxnz1A0-G-x7HTDOuROs_EtTy6Yt6PN_0F2cUyjbHSjWSikA_lBfdY-dDy5OSZuDabdsmFScS6EKdfofqhyLgzcxoPPl_a-Gl9cNJsWcE7puTH7Qad9x1h1C7-6GXvBnN7vO2wHtLfw7ZfELsQSlOw</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>Michalani, Maria Luiza Estimo</creator><creator>Passarelli, Marisa</creator><creator>Machado, Ubiratan Fabres</creator><general>MDPI AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7914-0107</orcidid><orcidid>https://orcid.org/0000-0002-8237-2435</orcidid><orcidid>https://orcid.org/0000-0002-9249-4698</orcidid></search><sort><creationdate>20240801</creationdate><title>Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of Slc2a4 Gene Expression in 3T3-L1 Adipocytes</title><author>Michalani, Maria Luiza Estimo ; Passarelli, Marisa ; Machado, Ubiratan Fabres</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-20abe17f916fb5d64efd0e2e12dd02eda7e520c4b460d4fec43d2f2474e5c8033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>3T3-L1 Cells</topic><topic>Adipocytes</topic><topic>Adipocytes - drug effects</topic><topic>Adipocytes - metabolism</topic><topic>Age</topic><topic>Animals</topic><topic>Biotechnology industry</topic><topic>Body fat</topic><topic>Dextrose</topic><topic>Diabetes</topic><topic>Ethylenediaminetetraacetic acid</topic><topic>Gene expression</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Glucose</topic><topic>Glucose Transporter Type 4 - genetics</topic><topic>Glucose Transporter Type 4 - metabolism</topic><topic>Glycation End Products, Advanced - metabolism</topic><topic>Glycation End Products, Advanced - pharmacology</topic><topic>Homeostasis</topic><topic>Insulin resistance</topic><topic>Kinases</topic><topic>Localization</topic><topic>Mice</topic><topic>Musculoskeletal system</topic><topic>Neurophysiology</topic><topic>NF-kappa B - metabolism</topic><topic>NF-kappa B p50 Subunit - genetics</topic><topic>NF-kappa B p50 Subunit - metabolism</topic><topic>Oxidative stress</topic><topic>Phosphorylation</topic><topic>Promoter Regions, Genetic</topic><topic>Proteins</topic><topic>Transcription Factor RelA - genetics</topic><topic>Transcription Factor RelA - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Michalani, Maria Luiza Estimo</creatorcontrib><creatorcontrib>Passarelli, Marisa</creatorcontrib><creatorcontrib>Machado, Ubiratan Fabres</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Michalani, Maria Luiza Estimo</au><au>Passarelli, Marisa</au><au>Machado, Ubiratan Fabres</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of Slc2a4 Gene Expression in 3T3-L1 Adipocytes</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2024-08-01</date><risdate>2024</risdate><volume>25</volume><issue>15</issue><spage>8242</spage><pages>8242-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Advanced glycated end products (AGEs) are cytotoxic compounds that are mainly increased in diabetes mellitus (DM), kidney failure, inflammation, and in response to the ingestion of AGE-rich diets. AGEs can also impair glycemic homeostasis by decreasing the expression of the (solute carrier family 2 member 4) gene and its GLUT4 (solute carrier family 2, facilitated glucose transporter member 4) protein in muscle. However, the mechanisms underlying AGE's effect on adipocytes have not been demonstrated yet. This study investigated the effects of AGEs upon /GLUT4 expression in 3T3-L1 adipocytes, as well as the potential role of NFKB (nuclear factor NF-kappa-B) activity in the effects observed. Adipocytes were cultured in the presence of control albumin (CA) or advanced glycated albumin (GA) at concentrations of 0.4, 3.6, and 5.4 mg/mL for 24 h or 72 h. , and mRNAs were measured by RT-qPCR, GLUT4, IKKA/B, and p50/p65 NFKB subunits using Western blotting, and p50/p65 binding into the promoter was analyzed by chromatin immunoprecipitation (ChIP) assay. GA at 0.4 mg/mL increased /GLUT4 expression after 24 h and 72 h (from 50% to 100%), but at 5.4 mg/mL, /GLUT4 expression decreased at 72 h (by 50%). and expression increased after 24 h at all concentrations, but this effect was not observed at 72 h. Furthermore, 5.4 mg/mL of GA increased the p50/p65 nuclear content and binding into at 72 h. In summary, this study reveals AGE-induced and NFKB-mediated repression of /GLUT4 expression. This can compromise the adipocyte glucose utilization, contributing not only to the worsening of glycemic control in DM subjects but also the impairment of glycemic homeostasis in non-DM subjects under the high intake of AGE-rich foods.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>39125811</pmid><doi>10.3390/ijms25158242</doi><orcidid>https://orcid.org/0000-0002-7914-0107</orcidid><orcidid>https://orcid.org/0000-0002-8237-2435</orcidid><orcidid>https://orcid.org/0000-0002-9249-4698</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2024-08, Vol.25 (15), p.8242
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_proquest_miscellaneous_3091287489
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central
subjects 3T3-L1 Cells
Adipocytes
Adipocytes - drug effects
Adipocytes - metabolism
Age
Animals
Biotechnology industry
Body fat
Dextrose
Diabetes
Ethylenediaminetetraacetic acid
Gene expression
Gene Expression Regulation - drug effects
Glucose
Glucose Transporter Type 4 - genetics
Glucose Transporter Type 4 - metabolism
Glycation End Products, Advanced - metabolism
Glycation End Products, Advanced - pharmacology
Homeostasis
Insulin resistance
Kinases
Localization
Mice
Musculoskeletal system
Neurophysiology
NF-kappa B - metabolism
NF-kappa B p50 Subunit - genetics
NF-kappa B p50 Subunit - metabolism
Oxidative stress
Phosphorylation
Promoter Regions, Genetic
Proteins
Transcription Factor RelA - genetics
Transcription Factor RelA - metabolism
title Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of Slc2a4 Gene Expression in 3T3-L1 Adipocytes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A47%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nuclear%20Factor-Kappa-B%20Mediates%20the%20Advanced%20Glycation%20End%20Product-Induced%20Repression%20of%20Slc2a4%20Gene%20Expression%20in%203T3-L1%20Adipocytes&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Michalani,%20Maria%20Luiza%20Estimo&rft.date=2024-08-01&rft.volume=25&rft.issue=15&rft.spage=8242&rft.pages=8242-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms25158242&rft_dat=%3Cgale_proqu%3EA804511435%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3090944322&rft_id=info:pmid/39125811&rft_galeid=A804511435&rfr_iscdi=true